搜尋結果
Slowing ALS Progression Through Gene Therapy
Forbes· 2 日前This story is part of a series on the current progression in Regenerative Medicine. In 1999, I ...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 5 日前The Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 2 日前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Sanjay Leela Bhansali Is ‘A Sharper Filmmaker’ After ‘Heeramandi’
Forbes· 2 日前In this exclusive interview, he dives deep into his cinematic vision, and opens up about being ...
Maternal deaths have fallen to pre-pandemic levels, new US data says
Bastillepost· 2 日前U.S. deaths of moms around the time of childbirth have fallen back to pre-pandemic levels, new ...
Amgen investors await weight-loss drug data
Reuters· 4 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
A Better Concept For mRNA Vaccines: Self-Amplification
Forbes· 6 日前Two new self-amplifying mRNA vaccines herald a new era of vaccination for coronaviruses.
Rescheduling Marijuana Won’t Reduce Regulatory Confusion On Drug’s Use
Forbes· 3 日前The Biden Administration is getting one step closer to rescheduling marijuana, according to The ...
Novo Boosts Wegovy Shipments as Lilly Rivalry Pressures Prices
Bloomberg· 3 日前Have a confidential tip for our reporters? Novo Nordisk A/S is shipping more introductory doses ...
California’s Diablo Canyon Plant Shows Nuclear Power’s Aging Problem
Forbes· 6 日前California’s Diablo Canyon nuclear power plant has had a tumultuous history. The plant’s two reactors came online in 1985 ...